Form 4: Strata Critical Medical Co-CEO Reports Stock Transactions

Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, reported the acquisition of 208,929 shares from PSU vesting and the disposition of 106,659 shares for tax obligations.

Summary

• Melissa M. Tomkiel, Co-CEO and General Counsel of Strata Critical Medical, Inc., reported changes in her beneficial ownership of Class A common stock.
• On October 31, 2025, she acquired 208,929 shares of Class A common stock at a price of $0 per share.
• This acquisition resulted from the certification of performance criteria for performance-based restricted stock units (PSUs) granted on March 8, 2024.
• Following this acquisition, her direct beneficial ownership increased to 1,479,301 shares.
• On November 3, 2025, 106,659 shares of Class A common stock were disposed of at a price of $5.03 per share.
• These shares were withheld by the Issuer to satisfy tax withholding obligations related to the PSU vesting.
• After the tax-related disposition, her direct beneficial ownership stands at 1,372,642 shares.

Sentiment

Score: 7

Explanation: The filing indicates that performance criteria for executive compensation were met, leading to the vesting of a significant number of shares. While some shares were sold for tax purposes, the underlying event (performance achievement) is positive.

Positives

• Co-CEO Melissa M. Tomkiel acquired 208,929 shares of Class A common stock, increasing her direct beneficial ownership to 1,479,301 shares before tax withholding.
• The acquisition was due to the satisfaction of performance criteria for previously granted performance-based restricted stock units (PSUs), indicating achievement of company goals.

Negatives

• 106,659 shares of Class A common stock were disposed of to cover tax withholding obligations, reducing direct beneficial ownership to 1,372,642 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased insider ownership (net of tax sales) can be seen as a positive signal of management's alignment with shareholder interests. The vesting of PSUs indicates the company met certain performance targets, which is generally positive for shareholders.
• Employees: The successful vesting of PSUs for an executive might signal a healthy compensation structure tied to performance.

Key Dates

Recommendation

This Form 4 reports routine insider transactions related to the vesting of performance-based restricted stock units and subsequent tax withholding. It indicates that performance criteria were met, which is a positive operational sign. However, these transactions are standard executive compensation events and do not provide new fundamental information to warrant a change in investment recommendation. The net change in beneficial ownership is a slight decrease after tax, but the underlying event of performance achievement is positive.

Keywords

Strata Critical Medical, SRTA, Form 4, insider trading, stock transaction, beneficial ownership, PSU, restricted stock units, executive compensation